Found: 6
Select item for more details and to access through your institution.
Comparison of Cabozantinib and Axitinib as Second-line Therapy After Nivolumab Plus Ipilimumab in Patients With Metastatic Clear Cell Renal Cell Carcinoma: A Comparative Analysis of Retrospective Real-world Data.
- Published in:
- Clinical Genitourinary Cancer, 2024, v. 22, n. 3, p. N.PAG, doi. 10.1016/j.clgc.2024.102094
- By:
- Publication type:
- Article
Epithelioid Angiomyolipoma with Tumor Thrombus into Inferior Vena Cava Presurgically Treated with Combination Therapy of Pembrolizumab and Axitinib: A Case Report.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Metastasis of malignant melanoma to urinary tract: a case report.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Paratesticular cellular angiofibroma: a case report.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Hepatic and lung methotrexate-associated polymorphic lymphoproliferative disorders arising during postoperative follow-up of renal cell carcinoma: a case report.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
The efficacy of second-line tyrosine kinase inhibitor for patients with metastatic non-clear cell renal cell carcinoma following first-line immune-oncology combination therapy.
- Published in:
- World Journal of Urology, 2024, v. 42, n. 1, p. 1, doi. 10.1007/s00345-024-05252-2
- By:
- Publication type:
- Article